News
HLS Therapeutics Inc. Opens the Market
TORONTO, March 16, 2018 /CNW/ - Bill Wells, Executive Chairman of the Board, HLS Therapeutics Inc. (HLS), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange, to open the market. HLS Therapeutics Inc. is a specialty pharmaceutical company focused on the acquisition and commercialization of late stage development, commercial stage promoted and established stage branded pharmaceutical products in the North American markets. HLS Therapeutics Inc. commenced trading on TSX Venture Exchange on March 14, 2018.
SOURCE TMX Group Limited